Oct 2026· Bioresource Technology· Vol 464, pp.
136054
· 0 citations· 107 references
Medicine
TL;DR
This review critically evaluates the progress and inherent challenges in reconstructing this intricate pathway within heterologous chassis, including Escherichia coli, Saccharomyces cerevisiae and plant-based systems, highlighting bottlenecks related to P450 catalytic efficiency, metabolic burden and product cytotoxicity.
Abstract
Paclitaxel remains irreplaceable in cancer therapy, yet its supply is critically constrained by the ecological unsustainability of plant extraction and the prohibitive costs of chemical synthesis. The recent and near-complete elucidation of its complex biosynthetic pathway in Taxus species has created a pivotal opportunity to transition toward sustainable microbial bioproduction. This review synthesizes the latest breakthroughs in the field, beginning with the comprehensive mapping of the paclitaxel biosynthetic network. This includes the recent discovery of key cytochrome P450 and 2-oxoglutarate/Fe(II)-dependent dioxygenase enzymes that resolve long standing questions regarding taxane core oxidation and oxetane ring formation. We critically evaluate the progress and inherent challenges in reconstructing this intricate pathway within heterologous chassis, including Escherichia coli, Saccharomyces cerevisiae and plant-based systems, highlighting bottlenecks related to P450 catalytic efficiency, metabolic burden and product cytotoxicity. Furthermore, this review explores emerging frontiers in synthetic biology, such as AI-driven enzyme engineering, the development of novel chassis like oleaginous yeast, the design of synthetic consortia and photosynthetic microalgae as promising platforms. By integrating fundamental pathway discovery with industrial application, this review provides insights for establishing a scalable, economically viable and environmentally sustainable supply of this essential agent.
The sustainable microbial production of high-value terpenoids like longifolene represents a critical frontier in green manufacturing, yet it is often hindered by systemic metabolic inefficiencies in microbial hosts. To address this, we present a comprehensive systems metabolic engineering framework in Saccharomyces cer...
Wei-Qiang Zhang, Ya-Chao Xin, Song Li et al.· Metabolic Engineering· 0 citations
Biomanufacturing has emerged as a strategic emerging industry worldwide, offering sustainable alternatives to conventional chemical manufacturing. To support this development, diverse production chassis have been developed, including microorganisms, mammalian cell culture systems, and plant-based platforms. Among these...
Yi Li, Yu-Fan Xing, Zi-Yue Wang et al.· Biotechnology Advances· 0 citations
A transformative framework to advance bioremediation from an empirically driven practice to a precisely targeted technology, paving the way for unequivocal detoxification of HOPs is established.
Qian Wang, Shuai Wang, Bo-Yang Zhu et al.· Critical Reviews in Environm...· 0 citations
This review highlights recent advances in PHA production by Streptomyces, focusing on metabolic pathways, omics-based insights, and bioprocess optimization strategies, focusing on metabolic pathways, omics-based insights, and bioprocess optimization strategies.
This review focuses on the bioconversion of lignin-derived syringyl monomers, which are characterized by 3,5-dimethoxy-substituted aromatic rings that create metabolic bottlenecks during microbial O-demethylation and ring cleavage.
Yu-Lu Wang, Hong-Wei Zhu, Xin-Yu Song et al.· International Journal of Bio...· 0 citations
Significant advances in integrated strategies, particularly organelle engineering in Yarrowia lipolytica and Saccharomyces cerevisiae, have increased squalene titers to high levels and provide a useful basis for future metabolic engineering efforts aimed at improving squalene production and facilitating the synthesis o...